Evidence map›Paper›PMID 35200155›Full record

ArticleJMIR mental health2022

The Impact of Long COVID-19 on Mental Health: Observational 6-Month Follow-Up Study.

Sarah Houben-Wilke, Yvonne Mj Goërtz, Jeannet M Delbressine, Anouk W Vaes, Roy Meys, Felipe Vc Machado, Maarten van Herck, Chris Burtin, Rein Posthuma, Frits Me Franssen and 5 more

Abstract read
In one paragraph

Article in JMIR mental health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Human brain matters: Navigating the neuropathology of COVID-19.Brain pathology (Zurich, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Long COVID-19: A Concept Analysis.Infectious disease reports · 2025
    Article
  18. Review
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sarah Houben-WilkeDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0001-6214-0365
Yvonne Mj GoërtzDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0003-4674-9562
Jeannet M DelbressineDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0002-5203-1592
Anouk W VaesDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0002-4136-1553
Roy MeysDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0002-4855-530X
Felipe Vc MachadoDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0003-1910-7695
Maarten van HerckDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0002-3333-6964
Chris BurtinREVAL Rehabilitation Research Center, BIOMED Research Institute, Faculty of Rehabilitation Sciences, Hasselt University, Diepenbeek, Belgium.ORCID https://orcid.org/0000-0002-1342-8554
Rein PosthumaDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0003-0015-0116
Frits Me FranssenDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0002-1633-6356
Herman VijlbriefLung Foundation Netherlands, Amersfoort, Netherlands.ORCID https://orcid.org/0000-0002-2676-5664
Yvonne SpiesLung Foundation Netherlands, Amersfoort, Netherlands.ORCID https://orcid.org/0000-0002-5400-0327
Alex J van 't HulDepartment of Pulmonary Disease, Radboud University Medical Center, Nijmegen, Netherlands.ORCID https://orcid.org/0000-0002-5514-2327
Martijn A SpruitDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0003-3822-7430
Daisy Ja JanssenDepartment of Research and Education, Ciro, Horn, Netherlands.ORCID https://orcid.org/0000-0002-1827-9869

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe psychological impact of COVID-19 can be substantial. However, knowledge about long-term psychological outcomes in patients with COVID-19 is scarce.

objectiveIn this longitudinal, observational study, we aimed to reveal symptoms of posttraumatic stress disorder (PTSD) and symptoms of anxiety and depression up to 6 months after the onset of COVID-19-related symptoms in patients with confirmed COVID-19 and persistent complaints. To demonstrate the impact in nonhospitalized patients, we further aimed to compare these outcomes between nonhospitalized and hospitalized patients.

methodsDemographics, symptoms of PTSD (Trauma Screening Questionnaire [TSQ] ≥6 points) and symptoms of anxiety and depression (Hospital Anxiety and Depression Scale [HADS] ≥8 points) were assessed at 3 and 6 months after the onset of COVID-19-related symptoms in members of online long COVID-19 peer support groups.

resultsData from 239 patients with confirmed COVID-19 (198/239, 82.8% female; median age: 50 [IQR 39-56] years) were analyzed. At the 3-month follow-up, 37.2% (89/239) of the patients had symptoms of PTSD, 35.6% (85/239) had symptoms of anxiety, and 46.9% (112/239) had symptoms of depression, which remained high at the 6-month follow-up (64/239, 26.8%, P=.001; 83/239, 34.7%, P=.90; 97/239, 40.6%, P=.08, respectively; versus the 3-month follow-up). TSQ scores and HADS anxiety and depression scores were strongly correlated at the 3- and 6-month follow-ups (r=0.63-0.71, P<.001). Symptoms of PTSD, anxiety, and depression were comparable between hospitalized (n=62) and nonhospitalized (n=177) patients.

conclusionsA substantial percentage of patients with confirmed COVID-19 and persistent complaints reported symptoms of PTSD, anxiety, or depression 3 and 6 months after the onset of COVID-19-related symptoms. The prevalence rates of symptoms of PTSD, anxiety, and depression were comparable between hospitalized and nonhospitalized patients and merely improved over time. Health care professionals need to be aware of these psychological complications and intervene on time in post-COVID-19 patients with persistent complaints.

trial registrationNetherlands Trial Register NTR8705; https://www.trialregister.nl/trial/8705.

Indexed as

anxietycoronaCOVID-19depressionPASCpost-traumatic stress disorderSARS-CoV-2

Identifiers

PMID35200155
PMCPMC8914795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.